| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 03/29/2001 | WO2001021812A1 Phosphatases which activate map kinase pathways |
| 03/29/2001 | WO2001021804A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 03/29/2001 | WO2001021799A1 Traf4 associated cell cycle proteins, compositions and methods of use |
| 03/29/2001 | WO2001021797A1 Rgs10b, a g-protein regulator expressed in osteoclasts |
| 03/29/2001 | WO2001021796A2 Gl50 molecules and uses therefor |
| 03/29/2001 | WO2001021790A1 Conditional immortalisation of cells |
| 03/29/2001 | WO2001021788A1 MAST CELL-SPECIFIC SIGNAL TRANSDUCING MOLECULES AND cDNAS THEREOF |
| 03/29/2001 | WO2001021784A2 Pcna-associated cell cycle proteins, compositions and methods of use |
| 03/29/2001 | WO2001021783A2 Seed-preferred promoter from maize |
| 03/29/2001 | WO2001021780A2 Targeted gene removal |
| 03/29/2001 | WO2001021771A2 Compositions and methods for inhibiting g2 cell cycle arrest and sensitizing cells to dna damaging agents |
| 03/29/2001 | WO2001021767A2 Pluripotent embryonic-like stem cells, compositions, methods and uses thereof |
| 03/29/2001 | WO2001021766A2 Methods and devices for obtaining non-hematopoietic lineage cells from hematopoietic progenitor cells |
| 03/29/2001 | WO2001021765A2 Method for the selective protection of proliferating normal cells and the selective eradication of tumor cells having an inactive p53 pathway |
| 03/29/2001 | WO2001021658A1 32 human secreted proteins |
| 03/29/2001 | WO2001021654A2 Syk kinase-associated cell cycle proteins, compositions and methods of use |
| 03/29/2001 | WO2001021644A2 Wheat dp proteins and uses thereof |
| 03/29/2001 | WO2001021640A1 Identification and functional characterization of a new subfamily of sulfatases |
| 03/29/2001 | WO2001021220A2 Bioprosthetic heart valves |
| 03/29/2001 | WO2001021215A1 Cell based assay |
| 03/29/2001 | WO2001021202A2 Treatment of chronic inflammatory disease by inhibiting sub-groups of activated t-cells |
| 03/29/2001 | WO2001021184A1 Cell-based gene therapy for the pulmonary system |
| 03/29/2001 | WO2001020999A1 Materials and methods for inducing angiogenesis and the repair of mammalian tissue |
| 03/29/2001 | WO2001020977A1 Novel animal model of alzheimer disease with amyloid plaques and mitochondrial dysfunctions |
| 03/29/2001 | WO2001020973A2 Plant genes for sensitivity to ethylene and pathogens |
| 03/29/2001 | WO2001002557A8 Neurotrophic factor receptor |
| 03/29/2001 | WO2001000843A3 Corynebacterium glutamicum genes encoding metabolic pathway proteins |
| 03/29/2001 | WO2000077026A8 49 human secreted proteins |
| 03/29/2001 | WO2000032775A9 Pth1r and pth3r receptors |
| 03/29/2001 | WO2000023615A3 Method for extracting quantitative information relating to an influence on a cellular response |
| 03/29/2001 | WO2000012741A9 Inducible expression system |
| 03/29/2001 | WO1999013083A9 Method and means for modulating plant cell cycle proteins and their use in controlling plant cell growth |
| 03/29/2001 | US20010000075 Neurotactin and uses therefor |
| 03/29/2001 | DE19944858A1 A monoantigen-presenting cell capable of dividing and with suppressed functionality of the co-stimulatory receptors B7 and CD40 |
| 03/29/2001 | DE19937548A1 Ein- oder mehrzellige Organismen zur Herstellung von Riboflavin Mono- or multicellular organisms for the production of riboflavin |
| 03/29/2001 | CA2388365A1 Helper vectors and cell lines for the production of pseudoadenoviral vectors |
| 03/29/2001 | CA2387695A1 A novel member of the heparanase protein family |
| 03/29/2001 | CA2385879A1 Traf4 associated cell cycle proteins, compositions and methods of use |
| 03/29/2001 | CA2385783A1 A pcam-1 marker protein, nucleic acid sequences encoding pcam-1 and immunoassays for detection of pcam-1 |
| 03/29/2001 | CA2385697A1 Method for identifying novel genes involved in the regulation of angiogenesis, study of said genes and use thereof for therapeutic purposes |
| 03/29/2001 | CA2385664A1 Recombinant phages capable of entering host cells via specific interaction with an artificial receptor |
| 03/29/2001 | CA2385552A1 Phosphatases which activate map kinase pathways |
| 03/29/2001 | CA2385480A1 32 human secreted proteins |
| 03/29/2001 | CA2385460A1 Rgs10b, a g-protein regulator expressed in osteoclasts |
| 03/29/2001 | CA2385428A1 Novel pcna-associated cell cycle proteins, compositions and methods of use |
| 03/29/2001 | CA2385424A1 Method for the selective protection of proliferating normal cells and the selective eradication of tumor cells having an inactive p53 pathway |
| 03/29/2001 | CA2385334A1 Novel syk kinase-associated cell cycle proteins, compositions and methods of use |
| 03/29/2001 | CA2385257A1 Compositions and methods for inhibiting g2 cell cycle arrest and sensitizing cells to dna damaging agents |
| 03/29/2001 | CA2385235A1 Checkpoint gene associated cell cycle proteins, compositions and methods of use |
| 03/29/2001 | CA2384973A1 Seed-preferred promoter from maize |
| 03/29/2001 | CA2384932A1 Targeted gene removal |
| 03/29/2001 | CA2384865A1 Novel animal model of alzheimer disease with amyloid plaques and mitochondrial dysfunctions |
| 03/29/2001 | CA2383591A1 Cell based assay |
| 03/29/2001 | CA2383462A1 Therapeutic methods and compounds |
| 03/29/2001 | CA2383253A1 Conditional immortalisation of cells |
| 03/29/2001 | CA2383093A1 Cell-based gene therapy for the pulmonary system |
| 03/28/2001 | EP1087017A2 The cytoplasmic inhibition of gene expression |
| 03/28/2001 | EP1087016A2 Agrobacterium tumefaciens transformation of musa species |
| 03/28/2001 | EP1087014A1 Hog cholera virus vaccine and diagnostic |
| 03/28/2001 | EP1086252A1 Herpes simplex virus origin binding protein n-terminal truncation (obp-nt) |
| 03/28/2001 | EP1086238A1 Human mp52 gene promoter and method for exploring useful substance by using the same |
| 03/28/2001 | EP1086237A2 Expression cassette for transformation comprising a modified viral sequence driven by a suitable promoter |
| 03/28/2001 | EP1086235A2 Corn oleosin promoter and genes encoding corn desaturases |
| 03/28/2001 | EP1086234A1 New human carboxypeptidase inhibitor |
| 03/28/2001 | EP1086232A1 A vaccine-induced hepatitis b viral strain and uses thereof |
| 03/28/2001 | EP1086230A1 Bactericidal/permeability-increasing protein (bpi) deletion analogs |
| 03/28/2001 | EP1086227A1 Novel maize orthologues of bacterial reca proteins |
| 03/28/2001 | EP1086225A2 Human tumour-derived polypeptide hormone phosphatonin |
| 03/28/2001 | EP1086223A2 Novel serpentine transmembrane antigens expressed in human cancers and uses thereof |
| 03/28/2001 | EP1086222A2 Cell cycle regulation proteins |
| 03/28/2001 | EP1086221A2 Truncated apaf-1 and methods of use thereof |
| 03/28/2001 | EP1086218A2 Genes and gene expression products that are differentially regulated in prostate cancer |
| 03/28/2001 | EP1086217A2 Novel angiotensin receptor, production and use thereof |
| 03/28/2001 | EP1086215A2 Preparation and use of superior vaccines |
| 03/28/2001 | EP1086212A2 Method and reagents for the treatment of diseases or conditions related to molecules involved in angiogenic responses |
| 03/28/2001 | EP1086211A2 Novel mannanases |
| 03/28/2001 | EP1086210A1 Novel mannanases |
| 03/28/2001 | EP1086206A2 Methods and apparatus for the conditioning of ligament replacement tissue |
| 03/28/2001 | EP1086138A2 Monoclonal antibodies, cross-reactive antibodies and method for producing the same |
| 03/28/2001 | EP1086137A1 Composition and method for modulating dendritic cell-t cell interaction |
| 03/28/2001 | EP1086136A1 Monoclonal antibodies specific for guanidino group-derived advanced glycosylation endproducts in biological samples |
| 03/28/2001 | EP1086132A1 Gene encoding organic anion transporter |
| 03/28/2001 | EP1086129A1 Anti-angiogenic proteins and methods of use thereof |
| 03/28/2001 | EP1086128A2 Plant protein with repeated wd40 motifs, nucleic acid coding for said protein, and uses thereof |
| 03/28/2001 | EP1085897A1 Acrp30r1l, a homolog of acrp30 (30 kd adipocyte complement-related protein) |
| 03/28/2001 | EP0495096B1 Plant fatty acid synthases |
| 03/28/2001 | CN1289369A Riboflavin biosynthesis genes from plants and uses thereof |
| 03/28/2001 | CN1289339A Genetic immunization with nonstructural proteins of hepatitis c virus |
| 03/28/2001 | CN1288953A Method of producing taxad alkane by using Chinese yew cell |
| 03/28/2001 | CN1063796C Preparation method for drythropoietin isoforms |
| 03/28/2001 | CN1063792C Hamanized antibodies and uses thereof |
| 03/27/2001 | US6207880 Plants which synthesize a modified starch, process for the production thereof and modified starch |
| 03/27/2001 | US6207814 Activin receptor-like kinases, ALK-3 and ALK-6, and nucleic acids encoding them |
| 03/27/2001 | US6207812 Chondrosarcoma associated genes |
| 03/27/2001 | US6207805 Hybridoma which secretes monoclonal antibodies; diagnosis; anticarcinogenic agents with reduced side effects; imaging |
| 03/27/2001 | US6207803 Amino acid sequence of polypeptide; anticarcinogenic agents; antitumor agents; treatment of automimmune disorders, blood disorders; alzheimer's/parkinson's disease, septic shock, osteoporosis, polycystic kidney disease; viricides; diagnosis |
| 03/27/2001 | US6207802 Non-human, mammalian polypeptide of defined amino acid sequence which activates the growth of early hematopoietic progenitor cells; treatment of blood disorders; anticarcinogenic agents; bone marrow regeneration |
| 03/27/2001 | US6207801 FADD-like anti-apoptotic molecules, methods of using the same, and compositions for and methods of making the same |
| 03/27/2001 | US6207799 Neuropeptide Y receptor Y5 and nucleic acid sequences |
| 03/27/2001 | US6207647 Polynucleotides and polypeptides of the rat family, referred to as ?rata?; treatment of chlamydia infections |